Kee Song Bio-Technology Holdings Limited

TPEX:1258 Voorraadrapport

Marktkapitalisatie: NT$988.6m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Kee Song Bio-Technology Holdings Beheer

Beheer criteriumcontroles 1/4

We currently do not have sufficient information about the CEO.

Belangrijke informatie

Kevin Tan

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEOless than a year
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuur12.3yrs

Recente managementupdates

Recent updates

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Mar 15
Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

Nov 30
Health Check: How Prudently Does Kee Song Bio-Technology Holdings (GTSM:1258) Use Debt?

CEO

Kevin Tan

less than a year

Tenure

Kevin Tan is General Manager of Kee Song Bio-Technology Holdings Limited from August 19, 2022. Kevin Tan is a COO of Kee Song Group.

Bestuursleden

NaamPositieTenureCompensatieEigendom
Boon-Yew Ng
Independent Director12.3yrsNT$749.00kgeen gegevens
Kian San Ong
Chairman13.1yrsgeen gegevensgeen gegevens
Xian-Tsai Wen
Independent Director12.3yrsNT$642.00kgeen gegevens
Chen Ying-Chieh
Director1.4yrsgeen gegevensgeen gegevens
Lee Hung Ching
Independent Director1.4yrsgeen gegevensgeen gegevens
Boon Zhao Chua
Independent Directorno dataNT$669.00kgeen gegevens

12.3yrs

Gemiddelde duur

Ervaren bestuur: 1258's board of directors are seasoned and experienced ( 12.3 years average tenure).